VistaGen Therapeutics Inc. (NASDAQ: VTGN)
$3.89
+0.0500 ( +1.30% ) 94.2K
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Market Data
Open
$3.89
Previous close
$3.84
Volume
94.2K
Market cap
$105.67M
Day range
$3.72 - $3.96
52 week range
$1.63 - $24.71
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Mar 06, 2024 |
4 | Insider transactions | 2 | Mar 06, 2024 |
4 | Insider transactions | 2 | Mar 06, 2024 |
4 | Insider transactions | 2 | Mar 06, 2024 |
4 | Insider transactions | 2 | Mar 06, 2024 |
8-k | 8K-related | 17 | Feb 13, 2024 |
10-q | Quarterly Reports | 50 | Feb 13, 2024 |
8-k | 8K-related | 76 | Jan 09, 2024 |
4 | Insider transactions | 2 | Jan 03, 2024 |
8-k | 8K-related | 15 | Jan 03, 2024 |